News items related to: News
-
TNP+ opposes patent claims on Lenacapavir
TNP+, MMA’s partner in Thailand, has filled an opposition against Markush patent claims on lenacapavir, a new, long-acting antiretroviral drug,...
-
In times of peace and in times of war: 100% LIFE outstanding work in Ukraine
After two years of the worst pandemic in recent history, 2022 marked an extra tragic event in the history of...
-
GSIPA2M – Day 2
Welcome to Day 2 of GISPA2M 2022! Plenary III – Big Pharma’s multiverse of Madness Andrew Hill, University of Liverpool,...
-
GSIPA2M – Day 1
Welcome to the first day of 2022 GSIPA2M – The Pandemic Edition: Reclaiming Access Sergiy Kondratyuk, ITPC Global, Ukraine Sergiy...
-
GSIPA2M 2022 – The Pandemic Edition: Reclaiming Access
Civil Society from across the globe will gather in Istanbul from the 19th to the 21st of July 2022 for...
-
Médecins du Monde challenges patents on COVID-19 vaccine
Médecins du Monde (MdM), a global medical humanitarian organization, has exposed Pfizer/BioNTechs’s patent abuse on the COVID-19 vaccine by challenging...
-
COVID Advocates Advisory Board meeting with Johnson & Johnson (J&J)/Janssen
Directly posted from CAAB Vax: Last November 15, a group of advocates working on vaccine access issues met with representatives...
-
TNP+ demands that Thailand’s Minister of Health “unlock” Hepatitis C treatment
On 7 February 2022, during Thailand’s National Health Security Board meeting, a representative from the Thai Network of People Living...
-
Fighting for access to better TB drugs in Thailand
Thailand is classified by the World Health Organisation as a tuberculosis (TB) /HIV high-burden country, including MDR-TB. It is estimated...
-
Ukraine fights for affordable access to a life-saving COVID-19 treatment
100% Life, MMA’s partner in Ukraine, has opposed a patent on tocilizumab, a monoclonal antibody that blocks interleukin-6, an inflammatory...
-
Georgia’s civil society opposes patents for HIV medicines
Network TBPeople, MMA’s partner in Georgia, has made progress in the fight against patent monopolies for life-saving drugs. Image ©...
-
Indonesia Issues Government Use Licenses for Remdesivir and Favipiravir
Make Medicines Affordable Campaign and ITPC welcome the Presidential Decrees issued in Indonesia for government use licenses on remdesivir and...